Report Detail
Global Post Herpetic Neuralgia Therapies
- RnM3350791 |
- 24 April, 2019 |
- Global |
- 98 Pages |
- QYResearch |
- Other
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
In 2018, the global Post Herpetic Neuralgia Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Post Herpetic Neuralgia Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Post Herpetic Neuralgia Therapies development in United States, Europe and China.
The key players covered in this study
Endo Pharmaceuticals
Depomed
Acorda Therapeutics
Pfizer
Mylan
Daiichi Sankyo
Teikoku Pharma
...
Market segment by Type, the product can be split into
Drugs
Patches
Steroid Injectable
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Post Herpetic Neuralgia Therapies status, future forecast, growth opportunity, key market and key players.
To present the Post Herpetic Neuralgia Therapies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Post Herpetic Neuralgia Therapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Drugs
- 1.4.3 Patches
- 1.4.4 Steroid Injectable
- 1.5 Market by Application
- 1.5.1 Global Post Herpetic Neuralgia Therapies Market Share by Application (2014-2025)
- 1.5.2 Hospital Pharmacies
- 1.5.3 Online Pharmacies
- 1.5.4 Retail Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Post Herpetic Neuralgia Therapies Market Size
- 2.2 Post Herpetic Neuralgia Therapies Growth Trends by Regions
- 2.2.1 Post Herpetic Neuralgia Therapies Market Size by Regions (2014-2025)
- 2.2.2 Post Herpetic Neuralgia Therapies Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Post Herpetic Neuralgia Therapies Market Size by Manufacturers
- 3.1.1 Global Post Herpetic Neuralgia Therapies Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio (CR5 and HHI)
- 3.2 Post Herpetic Neuralgia Therapies Key Players Head office and Area Served
- 3.3 Key Players Post Herpetic Neuralgia Therapies Product/Solution/Service
- 3.4 Date of Enter into Post Herpetic Neuralgia Therapies Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Post Herpetic Neuralgia Therapies Market Size by Type (2014-2019)
- 4.2 Global Post Herpetic Neuralgia Therapies Market Size by Application (2014-2019)
5 United States
- 5.1 United States Post Herpetic Neuralgia Therapies Market Size (2014-2019)
- 5.2 Post Herpetic Neuralgia Therapies Key Players in United States
- 5.3 United States Post Herpetic Neuralgia Therapies Market Size by Type
- 5.4 United States Post Herpetic Neuralgia Therapies Market Size by Application
6 Europe
- 6.1 Europe Post Herpetic Neuralgia Therapies Market Size (2014-2019)
- 6.2 Post Herpetic Neuralgia Therapies Key Players in Europe
- 6.3 Europe Post Herpetic Neuralgia Therapies Market Size by Type
- 6.4 Europe Post Herpetic Neuralgia Therapies Market Size by Application
7 China
- 7.1 China Post Herpetic Neuralgia Therapies Market Size (2014-2019)
- 7.2 Post Herpetic Neuralgia Therapies Key Players in China
- 7.3 China Post Herpetic Neuralgia Therapies Market Size by Type
- 7.4 China Post Herpetic Neuralgia Therapies Market Size by Application
8 Japan
- 8.1 Japan Post Herpetic Neuralgia Therapies Market Size (2014-2019)
- 8.2 Post Herpetic Neuralgia Therapies Key Players in Japan
- 8.3 Japan Post Herpetic Neuralgia Therapies Market Size by Type
- 8.4 Japan Post Herpetic Neuralgia Therapies Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Post Herpetic Neuralgia Therapies Market Size (2014-2019)
- 9.2 Post Herpetic Neuralgia Therapies Key Players in Southeast Asia
- 9.3 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Type
- 9.4 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Application
10 India
- 10.1 India Post Herpetic Neuralgia Therapies Market Size (2014-2019)
- 10.2 Post Herpetic Neuralgia Therapies Key Players in India
- 10.3 India Post Herpetic Neuralgia Therapies Market Size by Type
- 10.4 India Post Herpetic Neuralgia Therapies Market Size by Application
11 Central & South America
- 11.1 Central & South America Post Herpetic Neuralgia Therapies Market Size (2014-2019)
- 11.2 Post Herpetic Neuralgia Therapies Key Players in Central & South America
- 11.3 Central & South America Post Herpetic Neuralgia Therapies Market Size by Type
- 11.4 Central & South America Post Herpetic Neuralgia Therapies Market Size by Application
12 International Players Profiles
- 12.1 Endo Pharmaceuticals
- 12.1.1 Endo Pharmaceuticals Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Post Herpetic Neuralgia Therapies Introduction
- 12.1.4 Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
- 12.1.5 Endo Pharmaceuticals Recent Development
- 12.2 Depomed
- 12.2.1 Depomed Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Post Herpetic Neuralgia Therapies Introduction
- 12.2.4 Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
- 12.2.5 Depomed Recent Development
- 12.3 Acorda Therapeutics
- 12.3.1 Acorda Therapeutics Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Post Herpetic Neuralgia Therapies Introduction
- 12.3.4 Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
- 12.3.5 Acorda Therapeutics Recent Development
- 12.4 Pfizer
- 12.4.1 Pfizer Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Post Herpetic Neuralgia Therapies Introduction
- 12.4.4 Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
- 12.4.5 Pfizer Recent Development
- 12.5 Mylan
- 12.5.1 Mylan Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Post Herpetic Neuralgia Therapies Introduction
- 12.5.4 Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
- 12.5.5 Mylan Recent Development
- 12.6 Daiichi Sankyo
- 12.6.1 Daiichi Sankyo Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Post Herpetic Neuralgia Therapies Introduction
- 12.6.4 Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
- 12.6.5 Daiichi Sankyo Recent Development
- 12.7 Teikoku Pharma
- 12.7.1 Teikoku Pharma Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Post Herpetic Neuralgia Therapies Introduction
- 12.7.4 Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
- 12.7.5 Teikoku Pharma Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Post Herpetic Neuralgia Therapies . Industry analysis & Market Report on Post Herpetic Neuralgia Therapies is a syndicated market report, published as Global Post Herpetic Neuralgia Therapies . It is complete Research Study and Industry Analysis of Post Herpetic Neuralgia Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
